These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20823883)

  • 1. The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise.
    Council of the Global HIV Vaccine Enterprise
    Nat Med; 2010 Sep; 16(9):981-9. PubMed ID: 20823883
    [No Abstract]   [Full Text] [Related]  

  • 2. The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.
    Global HIV/AIDS Vaccine Enterprise
    PLoS Med; 2005 Feb; 2(2):e25. PubMed ID: 15740411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of HIV vaccine research and the role of the Global HIV Vaccine Enterprise.
    Voronin Y; Manrique A; Bernstein A
    Curr Opin HIV AIDS; 2010 Sep; 5(5):414-20. PubMed ID: 20978383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global HIV vaccine enterprise.
    Esparza J
    Int Microbiol; 2005 Jun; 8(2):93-101. PubMed ID: 16052457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2017 Keystone Symposium on HIV Vaccines.
    Cottrell CA; Ward AB
    Hum Vaccin Immunother; 2017 Oct; 13(10):2348-2351. PubMed ID: 28786733
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV vaccine efficacy trials: A brief history, and options for going forward.
    McKinnon LR; Card CM;
    AIDS Rev; 2010; 12(4):209-17. PubMed ID: 21179185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Funding support lacking in search for HIV vaccine.
    AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicine. The need for a global HIV vaccine enterprise.
    Klausner RD; Fauci AS; Corey L; Nabel GJ; Gayle H; Berkley S; Haynes BF; Baltimore D; Collins C; Douglas RG; Esparza J; Francis DP; Ganguly NK; Gerberding JL; Johnston MI; Kazatchkine MD; McMichael AJ; Makgoba MW; Pantaleo G; Piot P; Shao Y; Tramont E; Varmus H; Wasserheit JN
    Science; 2003 Jun; 300(5628):2036-9. PubMed ID: 12829768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Not if but how? Caring for HIV-1 vaccine trial participants in South Africa.
    Tucker T; Slack C
    Lancet; 2003 Sep; 362(9388):995. PubMed ID: 14513854
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-1C vaccine trial planned for South Africa.
    Ramsay S
    Lancet; 2000 Oct; 356(9238):1336. PubMed ID: 11073034
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines.
    Kent SJ; Cooper DA; Chhi Vun M; Shao Y; Zhang L; Ganguly N; Bela B; Tamashiro H; Ditangco R; Rerks-Ngarm S; Pitisuttithum P; Van Kinh N; Bernstein A; Osmanov S;
    PLoS Med; 2010 Sep; 7(9):e1000331. PubMed ID: 20877474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief history of the global effort to develop a preventive HIV vaccine.
    Esparza J
    Vaccine; 2013 Aug; 31(35):3502-18. PubMed ID: 23707164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia.
    Rerks-Ngarm S; Pitisuttithum P; Ganguly N; Zhang L; Tamashiro H; Cooper DA; Vun MC; Bela B; Ditangco R; Van Kinh N; Bernstein A; Osmanov S; Mathieson B; Kent SJ; Shao Y
    Curr Opin HIV AIDS; 2010 Sep; 5(5):435-52. PubMed ID: 20978386
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV vaccine trials in India.
    Berkley S
    Nat Biotechnol; 2008 May; 26(5):495; author reply 496. PubMed ID: 18464771
    [No Abstract]   [Full Text] [Related]  

  • 15. Expanding research capacity and accelerating AIDS vaccine development in Asia.
    Excler JL; Pitisuttithum P; Rerks-Ngarm S; Shao Y; Zhang L; Tamashiro H; Osmanov S;
    Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):766-84. PubMed ID: 19058617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical considerations in vaccine trials with special reference to candidate HIV vaccines.
    Fast PE; Sawyer LA; Wescott SL
    Pharm Biotechnol; 1995; 6():97-134. PubMed ID: 7551256
    [No Abstract]   [Full Text] [Related]  

  • 17. Cold shower for AIDS vaccines.
    Nat Med; 2007 Dec; 13(12):1389-90. PubMed ID: 18064013
    [No Abstract]   [Full Text] [Related]  

  • 18. Current strategies and limitations of HIV vaccines.
    Kawalekar OU; Shedlock DJ; Weiner DB
    Curr Opin Investig Drugs; 2010 Feb; 11(2):192-202. PubMed ID: 20112169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Don't stop me now.
    Nat Immunol; 2008 Aug; 9(8):821. PubMed ID: 18645584
    [No Abstract]   [Full Text] [Related]  

  • 20. Accelerating HIV-1 Vaccine Efficacy Trials.
    Barouch DH; Michael NL
    Cell; 2014 Nov; 159(5):969-972. PubMed ID: 25416935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.